286 related articles for article (PubMed ID: 20651387)
21. Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer.
Shi Q; Zhang Z; Neumann AS; Li G; Spitz MR; Wei Q
Carcinogenesis; 2005 Mar; 26(3):649-56. PubMed ID: 15579479
[TBL] [Abstract][Full Text] [Related]
22. Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population.
Nazki FH; Masood A; Banday MA; Bhat A; Ganai BA
Genet Mol Res; 2012 Apr; 11(2):906-17. PubMed ID: 22576918
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.
Zhai X; Gao J; Hu Z; Tang J; Qin J; Wang S; Wang X; Jin G; Liu J; Chen W; Chen F; Wang X; Wei Q; Shen H
BMC Cancer; 2006 May; 6():138. PubMed ID: 16723031
[TBL] [Abstract][Full Text] [Related]
24. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer.
Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L
Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882
[TBL] [Abstract][Full Text] [Related]
25. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
26. The presence of three repeats in the 5' UTR region of thymidylate synthase (TS) is associated with increased TS mRNA expression in cultured human cancer cell lines in vitro.
Hammad H; Sarkar M; Gupta N; Ardalan B; Subbarayan PR
Oncol Rep; 2012 Jan; 27(1):246-9. PubMed ID: 21947036
[TBL] [Abstract][Full Text] [Related]
27. A novel G/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele.
Gusella M; Bolzonella C; Crepaldi G; Ferrazzi E; Padrini R
Pharmacogenomics J; 2006; 6(6):421-4. PubMed ID: 16868573
[TBL] [Abstract][Full Text] [Related]
28. [Thymidylate synthase gene promoter polymorphism in patients with advanced head and neck cancer treated by radio- and 5-fluorouracil chemotherapy].
Kiss-László Z; Nagy B; Thurzó L; Szabó J
Magy Onkol; 2006; 50(1):33-7. PubMed ID: 16617381
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
[TBL] [Abstract][Full Text] [Related]
30. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.
Kawakami K; Omura K; Kanehira E; Watanabe Y
Anticancer Res; 1999; 19(4B):3249-52. PubMed ID: 10652619
[TBL] [Abstract][Full Text] [Related]
31. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
Takizawa M; Kawakami K; Obata T; Matsumoto I; Ohta Y; Oda M; Sasaki T; Watanabe G
Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
[TBL] [Abstract][Full Text] [Related]
32. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
Kawakami K; Salonga D; Park JM; Danenberg KD; Uetake H; Brabender J; Omura K; Watanabe G; Danenberg PV
Clin Cancer Res; 2001 Dec; 7(12):4096-101. PubMed ID: 11751507
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population.
Ko KH; Kim NK; Yim DJ; Hong SP; Park PW; Rim KS; Kim S; Hwang SG
Anticancer Res; 2006; 26(6B):4229-33. PubMed ID: 17201138
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.
Goekkurt E; Hoehn S; Wolschke C; Wittmer C; Stueber C; Hossfeld DK; Stoehlmacher J
Br J Cancer; 2006 Jan; 94(2):281-6. PubMed ID: 16317430
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms of folate pathway enzymes (methylenetetrahydrofolate reductase and thymidylate synthase) and their relationship with thymidylate synthase expression in human astrocytic tumors.
da Costa DM; de Lima GP; Faria MH; Rabenhorst SH
DNA Cell Biol; 2012 Jan; 31(1):57-66. PubMed ID: 21848426
[TBL] [Abstract][Full Text] [Related]
36. Association between polymorphisms of thymidylate synthase gene 5'- and 3'-UTR and gastric cancer risk: meta-analysis.
Mo A; Zhao Y; Shi Y; Qian F; Hao Y; Chen J; Yang S; Jiang Y; Luo Z; Yu P
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 28011897
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of thymidylate synthase gene and chemosensitivity of 5-fluorouracil regimen in metastatic gastrointestinal cancer.
Cui YH; Liu TS; Zhuang RY; Gao HJ; Li H
J Dig Dis; 2009 May; 10(2):118-23. PubMed ID: 19426394
[TBL] [Abstract][Full Text] [Related]
38. Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients.
Kuramochi H; Tanaka K; Oh D; Lehman BJ; Dunst CM; Yang DY; De Meester SR; Hagen JA; Danenberg KD; De Meester TR; Danenberg PV
Int J Oncol; 2008 Jan; 32(1):201-8. PubMed ID: 18097560
[TBL] [Abstract][Full Text] [Related]
39. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.
Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R
Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas.
Chen J; Kyte C; Chan W; Wetmur JG; Fuchs CS; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2247-50. PubMed ID: 15598787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
